從現有市場藥品之代謝物發展新型NMDA 受體調節劑---(子計畫二)合成與設計新型NMDA 受體調控劑治療精神分裂相關疾病
| dc.contributor.author | 孫仲銘 | en_US |
| dc.contributor.author | SUN CHUNG-MING | en_US |
| dc.contributor.department | 國立交通大學應用化學系(所) | zh_TW |
| dc.date.accessioned | 2014-12-13T10:52:01Z | |
| dc.date.available | 2014-12-13T10:52:01Z | |
| dc.date.issued | 2014 | en_US |
| dc.description.sponsorship | 科技部 | zh_TW |
| dc.identifier.govdoc | MOST103-2325-B009-001 | zh_TW |
| dc.identifier.uri | https://www.grb.gov.tw/search/planDetail?id=8385544&docId=450094 | en_US |
| dc.identifier.uri | https://ir.lib.nycu.edu.tw/handle/11536/103048 | |
| dc.language.iso | zh_TW | en_US |
| dc.title | 從現有市場藥品之代謝物發展新型NMDA 受體調節劑---(子計畫二)合成與設計新型NMDA 受體調控劑治療精神分裂相關疾病 | zh_TW |
| dc.title | Discovery and Synthesis of Novel N-Methyl D-Asperate (Nmda) Receptor Modulator for Their Therapeutic Utility in Schizophrenia | en_US |
| dc.type | Plan | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: